Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Michalik, A.
Right arrow Articles by Van Broeckhoven, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Michalik, A.
Right arrow Articles by Van Broeckhoven, C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, 2003, Vol. 12, Review Issue 2 R173-R186
DOI: 10.1093/hmg/ddg295
© 2003 Oxford University Press

Pathogenesis of polyglutamine disorders: aggregation revisited

Andrej Michalik and Christine Van Broeckhoven*

Department of Molecular Genetics, Neurogenetics Group, Flanders Interuniversity Institute for Biotechnology, University of Antwerp, Antwerpen, Belgium

Received June 25, 2003; Accepted August 14, 2003

Expansion of CAG trinucleotide repeats coding for polyglutamine in unrelated proteins causes at least nine late-onset progressive neurodegenerative disorders, including Huntington's disease and a number of spinocerebellar ataxias. Expanded polyglutamine provokes a dominant gain-of-function neurotoxicity, regardless of the specific protein context within which it resides. Nevertheless, the protein context does modulate polyglutamine toxicity, as evidenced by the distinct clinical and pathological features of the various disorders. Importantly, polyglutamine toxicity might derive from its ability to aggregate. Indeed, aggregation probably underlies some defining attributes of the polyglutamine disorders, such as their late onset, progressive nature, and the dependence of onset age on polyglutamine length. However, the central role of aggregation in polyglutamine pathogenesis has been challenged by several studies, which instead argued that the soluble form of the disease proteins is responsible for neuronal damage. Thus, the question whether polyglutamine aggregates are deleterious, harmless or protective remains the most passionately disputed issue in the study of these diseases. In this review, we attempt to reconcile some of these controversies.

* To whom correspondence should be addressed at: Department of Molecular Genetics VIB8, University of Antwerp, Universiteitsplein 1, B-2610 Antwerpen, Belgium. Tel: +32 38202601; Fax: +32 38202541; Email: christine.vanbroeckhoven{at}ua.ac.be


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 FASEB J.Home page
S. L. A. Wong, W. M. Chan, and H. Y. E. Chan
Sodium dodecyl sulfate-insoluble oligomers are involved in polyglutamine degeneration
FASEB J, September 1, 2008; 22(9): 3348 - 3357.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
H. Doi, K. Okamura, P. O. Bauer, Y. Furukawa, H. Shimizu, M. Kurosawa, Y. Machida, H. Miyazaki, K. Mitsui, Y. Kuroiwa, et al.
RNA-binding Protein TLS Is a Major Nuclear Aggregate-interacting Protein in Huntingtin Exon 1 with Expanded Polyglutamine-expressing Cells
J. Biol. Chem., March 7, 2008; 283(10): 6489 - 6500.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. A. Bolger, X. Zhao, T. J. Cohen, C.-C. Tsai, and T.-P. Yao
The Neurodegenerative Disease Protein Ataxin-1 Antagonizes the Neuronal Survival Function of Myocyte Enhancer Factor-2
J. Biol. Chem., October 5, 2007; 282(40): 29186 - 29192.
[Abstract] [Full Text] [PDF]

Home page
 Biophys. JHome page
A. Vitalis, X. Wang, and R. V. Pappu
Quantitative Characterization of Intrinsic Disorder in Polyglutamine: Insights from Analysis Based on Polymer Theories
Biophys. J., September 15, 2007; 93(6): 1923 - 1937.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Sano, S. Tokudome, N. Shimizu, N. Yoshikawa, C. Ogawa, K. Shirakawa, J. Endo, T. Katayama, S. Yuasa, M. Ieda, et al.
Intramolecular Control of Protein Stability, Subnuclear Compartmentalization, and Coactivator Function of Peroxisome Proliferator-activated Receptor {gamma} Coactivator 1{alpha}
J. Biol. Chem., August 31, 2007; 282(35): 25970 - 25980.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Biol.Home page
A. Janer, E. Martin, M.-P. Muriel, M. Latouche, H. Fujigasaki, M. Ruberg, A. Brice, Y. Trottier, and A. Sittler
PML clastosomes prevent nuclear accumulation of mutant ataxin-7 and other polyglutamine proteins
J. Cell Biol., July 3, 2006; 174(1): 65 - 76.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
H. Wang, P. J. Lim, C. Yin, M. Rieckher, B. E. Vogel, and M. J. Monteiro
Suppression of polyglutamine-induced toxicity in cell and animal models of Huntington's disease by ubiquilin
Hum. Mol. Genet., March 15, 2006; 15(6): 1025 - 1041.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
B. L. Apostol, K. Illes, J. Pallos, L. Bodai, J. Wu, A. Strand, E. S. Schweitzer, J. M. Olson, A. Kazantsev, J. L. Marsh, et al.
Mutant huntingtin alters MAPK signaling pathways in PC12 and striatal cells: ERK1/2 protects against mutant huntingtin-associated toxicity
Hum. Mol. Genet., January 15, 2006; 15(2): 273 - 285.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
D. Trochet, S. J. Hong, J. K. Lim, J.-F. Brunet, A. Munnich, K.-S. Kim, S. Lyonnet, C. Goridis, and J. Amiel
Molecular consequences of PHOX2B missense, frameshift and alanine expansion mutations leading to autonomic dysfunction
Hum. Mol. Genet., December 1, 2005; 14(23): 3697 - 3708.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
A. M. Bhattacharyya, A. K. Thakur, and R. Wetzel
Polyglutamine aggregation nucleation: Thermodynamics of a highly unfavorable protein folding reaction
PNAS, October 25, 2005; 102(43): 15400 - 15405.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
I. S. Seong, E. Ivanova, J.-M. Lee, Y. S. Choo, E. Fossale, M. Anderson, J. F. Gusella, J. M. Laramie, R. H. Myers, M. Lesort, et al.
HD CAG repeat implicates a dominant property of huntingtin in mitochondrial energy metabolism
Hum. Mol. Genet., October 1, 2005; 14(19): 2871 - 2880.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
C. Cecchi, S. Baglioni, C. Fiorillo, A. Pensalfini, G. Liguri, D. Nosi, S. Rigacci, M. Bucciantini, and M. Stefani
Insights into the molecular basis of the differing susceptibility of varying cell types to the toxicity of amyloid aggregates
J. Cell Sci., August 1, 2005; 118(15): 3459 - 3470.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
C. J. McLeod, L. V. O'Keefe, and R. I. Richards
The pathogenic agent in Drosophila models of 'polyglutamine' diseases
Hum. Mol. Genet., April 15, 2005; 14(8): 1041 - 1048.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
A. B. Bowman, S.-Y. Yoo, N. P. Dantuma, and H. Y. Zoghbi
Neuronal dysfunction in a polyglutamine disease model occurs in the absence of ubiquitin-proteasome system impairment and inversely correlates with the degree of nuclear inclusion formation
Hum. Mol. Genet., March 1, 2005; 14(5): 679 - 691.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
J.-C. Lievens, T. Rival, M. Iche, H. Chneiweiss, and S. Birman
Expanded polyglutamine peptides disrupt EGF receptor signaling and glutamate transporter expression in Drosophila
Hum. Mol. Genet., March 1, 2005; 14(5): 713 - 724.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
H. Adachi, M. Katsuno, M. Minamiyama, M. Waza, C. Sang, Y. Nakagomi, Y. Kobayashi, F. Tanaka, M. Doyu, A. Inukai, et al.
Widespread nuclear and cytoplasmic accumulation of mutant androgen receptor in SBMA patients
Brain, March 1, 2005; 128(3): 659 - 670.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D. Helmlinger, J. Bonnet, J.-L. Mandel, Y. Trottier, and D. Devys
Hsp70 and Hsp40 Chaperones Do Not Modulate Retinal Phenotype in SCA7 Mice
J. Biol. Chem., December 31, 2004; 279(53): 55969 - 55977.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. Gorbea, G. M. Goellner, K. Teter, R. K. Holmes, and M. Rechsteiner
Characterization of Mammalian Ecm29, a 26 S Proteasome-associated Protein That Localizes to the Nucleus and Membrane Vesicles
J. Biol. Chem., December 24, 2004; 279(52): 54849 - 54861.
[Abstract] [Full Text] [PDF]

Home page
 J. Med. Genet.Home page
S Caburet, A Demarez, L Moumne, M Fellous, E De Baere, and R A Veitia
A recurrent polyalanine expansion in the transcription factor FOXL2 induces extensive nuclear and cytoplasmic protein aggregation
J. Med. Genet., December 1, 2004; 41(12): 932 - 936.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
J. Amiel, D. Trochet, M. Clement-Ziza, A. Munnich, and S. Lyonnet
Polyalanine expansions in human
Hum. Mol. Genet., October 1, 2004; 13(suppl_2): R235 - R243.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
E. Trushina, R. B. Dyer, J. D. Badger II, D. Ure, L. Eide, D. D. Tran, B. T. Vrieze, V. Legendre-Guillemin, P. S. McPherson, B. S. Mandavilli, et al.
Mutant Huntingtin Impairs Axonal Trafficking in Mammalian Neurons In Vivo and In Vitro
Mol. Cell. Biol., September 15, 2004; 24(18): 8195 - 8209.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
R. de Pril, D. F. Fischer, M. L.C. Maat-Schieman, B. Hobo, R. A.I. de Vos, E. R. Brunt, E. M. Hol, R. A.C. Roos, and F. W. van Leeuwen
Accumulation of aberrant ubiquitin induces aggregate formation and cell death in polyglutamine diseases
Hum. Mol. Genet., August 15, 2004; 13(16): 1803 - 1813.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.